Loading…
Advancing Research for Chronic Pain Act of 2024
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2025 · third_quarter · Health Issues
S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. S. 2922/H.R. 7164 Advancing Research for Chronic Pain Act of 2024. Proposals related to digital health technologies and innovations. Proposals to advance policies related to effective pain management. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).
Client expense: $1,128,989 · Firm income: Not reported
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE, State, Dept of (DOS)
2024 · third_quarter · Health Issues
Issues pertaining to Pharmacy Benefit Managers Drug Affordability - H.R. 830, S. 1375 - the HELP Copays Act Step therapy reform - S. 6452 & H.R. 2630 - the Safe Step Act Neuroscience Drug Program - FY 2025 AgFDA Approps BRAIN Initiative - FY 2025 Labor-HHS Appropriations Migraine care - FY 2025 MilCon Approps Chronic Pain Research - H.R. 7164 Advancing Research for Chronic Pain Act; S. 3393 - SUPPORT for Patients and Communities Reauthorization Act BOLD Infrastructure for Alzheimers Reauthorization Act - H.R. 7218, S. 3775
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Issues pertaining to Pharmacy Benefit Managers Drug Affordability - H.R. 830, S. 1375 - the HELP Copays Act Step therapy reform - S. 6452 & H.R. 2630 - the Safe Step Act Neuroscience Drug Program - FY 2025 AgFDA Approps BRAIN Initiative - FY 2025 Labor-HHS Appropriations Migraine care - FY 2025 MilCon Approps Chronic Pain Research - H.R. 7164 Advancing Research for Chronic Pain Act; S. 3393 - SUPPORT for Patients and Communities Reauthorization Act BOLD Infrastructure for Alzheimers Reauthorization Act - H.R. 7218, S. 3775
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Issues pertaining to Pharmacy Benefit Managers Drug Affordability - H.R. 830, S. 1375 - the HELP Copays Act Step therapy reform - S. 6452 & H.R. 2630 - the Safe Step Act Neuroscience Drug Program - FY 2024 & FY 2025 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations BRAIN Initiative - FY 2024 & FY 2025 Departments of Labor, Health and Human Services, and Education; and Related Agencies Appropriations R&D Tax Credit Migraine care - Fiscal Year 2024 MilCon Approps Chronic Pain Research - H.R. 7164 Advancing Research for Chronic Pain Act; S. 3393 - SUPPORT for Patients and Communities Reauthorization Act BOLD Infrastructure for Alzheimers Reauthorization Act - H.R. 7218, S. 3775 ORPHAN Cures Act - H.R. 5539, S. 3131
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| NY |
| Terri A. Sewell | Democratic | AL |
| Zachary Nunn | Republican | IA |